Joshua Levine - Accuray Incorporated CEO and President and Director
| ARAY Stock | USD 2.21 0.02 0.91% |
CEO
Mr. Joshua H. Levine is a President, Chief Executive Officer, Director of Accuray Inc., since October 12, 2012. He was the President, Chief Executive Officer, and a director of two other publicly traded global medical device firms, including Mentor Corporationrationration, a surgical implantmedical device manufacturer in the aesthetics space from 2004 to 2009, and, prior to joining Accuray, with Immucor Corporationrationration, a diagnostics manufacturer of automated instrumentation and reagents used in blood transfusion procedures. Mr. Levine currently serves on the Board of Directors of Natus Medical Incorporated, a provider of medical devices, software services for the newborn care, neurology, sleep, hearing and balance markets since 2012.
| Age | 66 |
| Tenure | 12 years |
| Address | 1240 Deming Way, Madison, WI, United States, 53717-1954 |
| Phone | 608 824 2800 |
| Web | https://www.accuray.com |
Accuray Incorporated Management Efficiency
Return On Capital Employed is likely to rise to 0.01 in 2024, whereas Return On Tangible Assets are likely to drop (0.02) in 2024. Fixed Asset Turnover is likely to rise to 9.14 in 2024, whereas Total Assets are likely to drop slightly above 388.6 M in 2024. Accuray Incorporated's management efficiency ratios could be used to measure how well Accuray Incorporated manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Charles Goodwin | Apyx Medical | 52 | |
| Taylor Harris | Cutera Inc | 48 | |
| Joel Becker | Neuropace | 56 | |
| Jeffrey Dunn | Si Bone | 63 | |
| Gary Maharaj | SurModics | 61 | |
| Mark Throdahl | Orthopediatrics Corp | 73 | |
| Joseph Woody | Avanos Medical | 58 | |
| James Reinstein | Cutera Inc | 52 | |
| Charles II | Apyx Medical | 57 | |
| Phillip Chan | Cytosorbents Crp | 44 | |
| Charles Sherwood | Anika Therapeutics | 69 | |
| Karen Zaderej | Axogen Inc | 62 | |
| Joseph Burnett | Clearpoint Neuro | 47 | |
| Gary Crosby | Paragon 28 | 61 | |
| Robert Claypoole | Bioventus | 52 | |
| Bradley Mason | Orthofix Medical | 63 | |
| David Mowry | Cutera Inc | 62 | |
| Massimo Calafiore | Orthofix Medical | N/A | |
| Kevin Connors | Cutera Inc | 52 | |
| Albert DaCosta | Paragon 28 | 50 | |
Management Performance
| Return On Equity | -0.29 | ||||
| Return On Asset | 1.0E-4 |
Accuray Incorporated Leadership Team
Elected by the shareholders, the Accuray Incorporated's board of directors comprises two types of representatives: Accuray Incorporated inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accuray. The board's role is to monitor Accuray Incorporated's management team and ensure that shareholders' interests are well served. Accuray Incorporated's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accuray Incorporated's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emad Rizk, Independent Director | ||
| Melanie Gebauer, Vice Resources | ||
| Kevin Waters, CFO and Sr. VP | ||
| GS Jha, Global Officer | ||
| Robert Weiss, Independent Director | ||
| Beverly Huss, Director | ||
| Jesse Chew, Chief VP | ||
| Sandeep Chalke, Senior Officer | ||
| Andy Kirkpatrick, Senior Vice President - Global Operations | ||
| Richard Pettingill, Independent Director | ||
| John Dunn, Chief President | ||
| Jack Goldstein, Independent Director | ||
| Joseph Whitters, Director | ||
| Joshua Levine, CEO and President and Director | ||
| JeanPhilippe Pignol, Chief VP | ||
| Franco Palomba, Chief VP | ||
| Shig Hamamatsu, Vice President Finance and Chief Accounting Officer, Principal Accounting Officer | ||
| Louis Lavigne, Independent Chairperson of the Board | ||
| Lionel Hadjadjeba, Senior Vice President Chief Commercial Officer | ||
| Patrick Spine, Sr Officer | ||
| Ana Petrovic, Vice President | ||
| Dennis Winger, Independent Director | ||
| Ken Mobeck, VP Relations | ||
| Alaleh Nouri, Sr. VP, General Counsel and Corporate Secretary | ||
| Juki Hozumi, President Region | ||
| Suzanne MBA, CEO President | ||
| Doug Sherk, IR Contact Officer | ||
| Gina Corradetti, Chief VP | ||
| Beth Kaplan, Public Director | ||
| Michael Hoge, Senior Operations | ||
| Kelly Londy, COO and Executive VP | ||
| Ali Pervaiz, Senior CFO | ||
| Elizabeth Davila, Independent Vice Chairperson of the Board |
Accuray Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Accuray Incorporated a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | ||||
| Return On Asset | 1.0E-4 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 312.12 M | ||||
| Shares Outstanding | 99.17 M | ||||
| Shares Owned By Insiders | 3.57 % | ||||
| Shares Owned By Institutions | 66.35 % | ||||
| Number Of Shares Shorted | 5.27 M | ||||
| Price To Earning | 44.00 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Accuray Incorporated in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Accuray Incorporated's short interest history, or implied volatility extrapolated from Accuray Incorporated options trading.
Pair Trading with Accuray Incorporated
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Accuray Incorporated position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accuray Incorporated will appreciate offsetting losses from the drop in the long position's value.Moving together with Accuray Stock
| 0.64 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Accuray Stock
| 0.7 | GCTK | GlucoTrack | PairCorr |
| 0.55 | WST | West Pharmaceutical Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Accuray Incorporated could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Accuray Incorporated when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Accuray Incorporated - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Accuray Incorporated to buy it.
The correlation of Accuray Incorporated is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Accuray Incorporated moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Accuray Incorporated moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Accuray Incorporated can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accuray Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Accuray Stock please use our How to Invest in Accuray Incorporated guide.Note that the Accuray Incorporated information on this page should be used as a complementary analysis to other Accuray Incorporated's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Accuray Stock analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Accuray Incorporated's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accuray Incorporated. If investors know Accuray will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accuray Incorporated listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (0.14) | Revenue Per Share 4.64 | Quarterly Revenue Growth 0.168 | Return On Assets 0.0001 |
The market value of Accuray Incorporated is measured differently than its book value, which is the value of Accuray that is recorded on the company's balance sheet. Investors also form their own opinion of Accuray Incorporated's value that differs from its market value or its book value, called intrinsic value, which is Accuray Incorporated's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accuray Incorporated's market value can be influenced by many factors that don't directly affect Accuray Incorporated's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accuray Incorporated's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accuray Incorporated is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accuray Incorporated's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.